HealthQuest Adds BD (Becton, Dickinson and Company) Executive Chairman Vince Forlenza to Its Board of Advisors
SILICON VALLEY, Calif., Jan. 6, 2021 /PRNewswire/ -- HealthQuest Capital, a growth capital firm investing in commercial stage healthcare companies that meaningfully improve patient outcomes and reduce costs in healthcare, today announced that Vince Forlenza, executive chairman, and prior CEO of BD (Becton, Dickinson and Company), has joined the firm's board of advisors. As an advisor, Forlenza will work with HealthQuest to identify, develop and grow transformative companies with the potential to fundamentally and dynamically improve the healthcare industry.
Forlenza joins an advisory board that includes leading executives representing Bon Secours Mercy Health, Humana, Johnson & Johnson, LabCorp, Mayo Clinic (Florida), Medtronic, and Procter & Gamble. In 2020, HealthQuest also recruited Regina Benjamin, the 18th U.S. Surgeon General to the Board.
Forlenza has held multiple roles of increasing responsibility at BD. Key appointments included leadership roles as senior vice president of Technology, Strategy and Development; president of BD Biosciences; and executive vice president and president of BD Diagnostics. Forlenza was named president of BD in January 2009, assumed additional responsibility as chief operating officer in July 2010, became chief executive officer in October 2011 and chairman of the board in July 2012. During his eight years as CEO, BD built a powerful portfolio of solutions to advance the entire health care continuum, more than doubled annual revenue, and increased market capitalization by more than 300 percent.